Reading the tape
NYSE: ELV
Elevance Health Inc.
Healthcare · Medical - Healthcare Plans
Market Cap
$80.93B
52w High
$424.24
52w Low
$273.71
P/E
15.67
Volume
571.99K
Outstanding Shares
217.16M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
1Y Price: -8.73%Revenue (TTM): 9.44%FCF (TTM): 75.56%P/FCF: 36th pct
What changed
The stock fell 8.73% over the last year. Revenue grew 9.44% over the trailing twelve months. Operating margin moved from 4.82% to 3.81%. Free cash flow grew 75.56% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 3.81%. A decisive move in revenue — currently up 9.44% — would be the clearest signal to resolve the ambiguity.
Company profile
Elevance Health Inc. operates as a health benefits company.
CEOGail Koziara Boudreaux
SectorHealthcare
IndustryMedical - Healthcare Plans
Employees104,200
IPO dateOct 30, 2001
Valuation
Forward P/E—
EV/EBITDA10.51
Enterprise value$101.5B
Price / Book1.84
Stock splits
Jun 1, 2005↑ Forward
Every 1 shares became 2
Profitability & growth
Standard profitability metrics can be misleading for financial/insurance companies. GAAP requires unrealized investment gains/losses in net income (affecting ROE), and margins are blended across diverse business segments.
Revenue growth2.64%
Gross margin23.16%▼8.22%vs FY2024
Operating margin3.81%▼18.96%vs FY2024
ROE12.9%▼10.86%vs FY2024
Analyst consensus
RatingBuy
Target price$382.38▲2.60%
26
Buy
11
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 16, 2026
Q3 FY26 · EPS est $6.20 · Revenue est $48.77B
View
Dividends
$6.86/shareQuarterlyDividend Achiever · 14yrSafeELV pays a dividend with a 1.84% declared yield, 14 consecutive years of growth, growing at 10.52% annually, covered 2.1× by free cash flow.
Declared Yield
1.84%
Annual Div / Share
$6.86
5yr CAGR
+10.52%
Doubles every ~6.9yr
Payout Ratio
28.97%
Safe
Dividend Growth Rate
3yr CAGR
+7.51%
5yr CAGR
+10.52%
10yr CAGR
+10.4%
Dividend Safety
10/10Safe
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2026$6.86+2.7%
2025$6.68+7.4%
2024$6.22+12.7%
2023$5.52+14.5%
2022$4.82+15.9%
2021$4.16+18.9%
2020$3.50+12.9%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$18/yr
$2/mo
In 5 yrs
$30/yr+65%
$3/mo
In 10 yrs
$50/yr+172%
$4/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$18/yr $2/mo | $30/yr+65% $3/mo | $50/yr+172% $4/mo |
Yield-on-cost grows from 1.84% → 5.01% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
ELV has raised its dividend for 14 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 2.1× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 10.52% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
No strong risk signal stands out from the latest period pair.
Congressional Activity
Congress Trades in ELV
STOCK Act disclosures from senators and representatives.
Markwayne Mullin
OKsenateRepublicanPurchaseJoint2025-12-29$15,001 - $50,000+17d to disclose